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Abstract 
Background: Plasmodium invasion of the mosquito midgut is a population bottleneck in the parasite lifecycle. Inter-
ference with molecular mechanisms by which the ookinete invades the mosquito midgut is one potential approach 
to developing malaria transmission-blocking strategies. Plasmodium aspartic proteases are one such class of potential 
targets: plasmepsin IV (known to be present in the asexual stage food vacuole) was previously shown to be involved 
in Plasmodium gallinaceum infection of the mosquito midgut, and plasmepsins VII and plasmepsin X (not known to 
be present in the asexual stage food vacuole) are upregulated in Plasmodium falciparum mosquito stages. These (and 
other) parasite-derived enzymes that play essential roles during ookinete midgut invasion are prime candidates for 
transmission-blocking vaccines.
Methods: Reverse transcriptase PCR (RT-PCR) was used to determine timing of P. falciparum plasmepsin VII (PfPM VII) 
and plasmepsin X (PfPM X) mRNA transcripts in parasite mosquito midgut stages. Protein expression was confirmed 
by western immunoblot and immunofluorescence assays (IFA) using anti-peptide monoclonal antibodies (mAbs) 
against immunogenic regions of PfPM VII and PfPM X. These antibodies were also used in standard membrane feed-
ing assays (SMFA) to determine whether inhibition of these proteases would affect parasite transmission to mosqui-
toes. The Mann–Whitney U test was used to analyse mosquito transmission assay results.
Results: RT-PCR, western immunoblot and immunofluorescence assay confirmed expression of PfPM VII and PfPM 
X in mosquito stages. Whereas PfPM VII was expressed in zygotes and ookinetes, PfPM X was expressed in gametes, 
zygotes, and ookinetes. Antibodies against PfPM VII and PfPM X decreased P. falciparum invasion of the mosquito 
midgut when used at high concentrations, indicating that these proteases play a role in Plasmodium mosquito mid-
gut invasion. Failure to generate genetic knockouts of these genes limited determination of the precise role of these 
proteases in parasite transmission but suggests that they are essential during the intraerythrocytic life cycle.
Conclusions: PfPM VII and PfPM X are present in the mosquito-infective stages of P. falciparum. Standard membrane 
feeding assays demonstrate that antibodies against these proteins reduce the infectivity of P. falciparum for mosqui-
toes, suggesting their viability as transmission-blocking vaccine candidates. Further study of the role of these plas-
mepsins in P. falciparum biology is warranted.
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Background
Despite reduced incidence and mortality rates malaria 
continues to have a significant global impact with more 
than 200 million people infected and a reported 438,000 
deaths in 2015 alone [1]. Malaria is initiated when sporo-
zoites are injected into a human from the bite of a Plas-
modium-infected anopheline mosquito, with severe 
disease most often due to Plasmodium falciparum. 
Increasing resistance to common anti-malarial drugs and 
the lack of an effective vaccine enhance the importance 
of malaria as a global scourge requiring new approaches, 
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including novel vaccine approaches to simultaneously 
target multiple parasite stages [2]. In addition to sporo-
zoite-targeting malaria vaccine approaches that aim to 
prevent initial human infection, complementary lines of 
malaria vaccine research have also focused on so-called 
transmission-blocking vaccines or, as newly articulated 
“vaccines that interrupt malaria transmission” [2], which 
aim to prevent humans with Plasmodium gametocytae-
mia from infecting the mosquito vector [3, 4]. Transmis-
sion-blocking vaccines target proteins expressed on or 
secreted by sexual stage parasites, which develop in the 
mosquito midgut [5].
Anopheles species mosquitoes are the definitive hosts 
of Plasmodium parasites, which obligatorily complete 
development from sexual stages to sporozoites within the 
mosquito before transmission to humans. Upon ingestion 
by the mosquito, environmental changes encountered 
in the midgut stimulate mature gametocyte emergence 
from infected erythrocytes, in a process known as game-
togenesis [6, 7]. Sexually dimorphic gametes fuse to gen-
erate zygotes in the midgut lumen. Zygotes then undergo 
sexual recombination and meiotic replication followed by 
transformation into polarized, motile ookinetes [8–10]. 
Ookinetes penetrate the midgut epithelium and form 
oocysts on the basal lamina. One ookinete that pene-
trates the midgut wall to form an oocyst has the poten-
tial to generate thousands of sporozoites, the form of the 
parasite that infects humans [11, 12]. Ookinete invasion 
of mosquito midgut is an important process for malaria 
transmission, but little is known about the molecular 
mechanisms involved.
Ookinetes produce stage-specific proteins important 
for subsequent midgut invasion, such as chitinase [13, 
14], circumsporozoite- and thrombospondin-related 
adhesive protein [TRAP]-related protein (CTRP) [15, 
16], von Willebrand A domain-related protein (WARP) 
[17, 18], Plasmodium 25/28 zygote/ookinete surface 
proteins (P25/28) [9, 19, 20], secreted ookinete adhesive 
protein (SOAP) [16, 21], and membrane attack perforin 
(MAOP) [22] amongst others. Because proteases play 
important roles during parasite infection of and develop-
ment in the mosquito, they were considered as potential 
transmission-blocking vaccine targets [23–28]. Tran-
scriptomic data suggested that Plasmodium aspartic pro-
teases, known as plasmepsins, are expressed in sexual 
stage parasites [29]. The P. falciparum genome encodes 
ten Plasmodium aspartic proteases known as plas-
mepsins [30]. Plasmepsins I, II, IV and HAP are present 
in the asexual blood stage parasite food vacuole and are 
involved in haemoglobin degradation in the food vacu-
ole of blood stage parasites [30–35]. In the endoplasmic 
reticulum of asexual blood stage parasites, Plasmepsin V 
processes proteins and directs export of effector proteins 
[36]. Plasmepsin VI plays an as-yet undefined but impor-
tant role in parasite sporogonic development, particularly 
in early oocyst development in Plasmodium berghei [37]. 
Plasmepsin IV, in addition to its known role in haemo-
globin degradation, is involved in Plasmodium ookinete 
invasion of the mosquito midgut [38].
Transcriptomic data have shown that P. falciparum 
plasmepsin VII (PfPM VII) mRNA is present in game-
tocytes, and plasmepsin X (PfPM X) mRNA is present 
during both in gametocytes and in zygotes and ookine-
tes [29]. The biological functions of PfPM VII and PfPMX 
remain unknown. Based on these observations, this study 
aimed to test the hypothesis that PfPM VII and PfPM 
X are targets of blocking mosquito midgut infection by 
P. falciparum. Such data would support the notion that 
these proteins would contribute to the interaction of the 
P. falciparum ookinete with the anopheline midgut and 
provide the basis for further development of these mol-




Plasmodium falciparum strain NF54 from a master cell 
bank was used in this study, kindly provided under a 
material transfer agreement with Sanaria, Inc, Rockville, 
MD, USA. Parasites were maintained in asexual culture 
according to standard protocol [39]. Gametocytes and 
gametes were cultured in  vitro according to the Ifediba 
and Vanderberg [40] modification of the Trager and 
Jensen method [41]; zygotes and ookinetes were cultured 
and purified as described [42–44].
Anopheles gambiae and Anopheles stephensi used in 
this study were a generous gift from Dr. Anthony James 
(University of California Irvine, Irvine, CA USA). Mos-
quitoes were maintained in an enclosed insectary at 26 °C 
and 80  % humidity with an automated 12-h light–dark 
cycle according to standard CDC protocol [45]. Mos-
quitoes used in this study were closely monitored and 
controlled according to the protocol for non-vertebrate 
animal subjects approved by the UCSD Institutional Ani-
mal Care and Use Committee (IACUC).
DNA/RNA isolation and RT‑PCR
Plasmodium parasites were either generated in  vitro 
or isolated ex  vivo from infected mosquitoes. For 
ex  vivo-isolated mosquito-stage parasite samples, 
midguts from mosquitoes were dissected and homog-
enized; five midguts were pooled per sample at 24  h 
post-engorgement. Genomic DNA was isolated using 
NucleoSpin Blood (Macherey–Nagel, Bethlehem, PA, 
USA). Total RNA was isolated using RNeasy (Qia-
gen, Valencia, CA, USA) and contaminating DNA was 
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removed using DNA-free (Ambion, Austin, TX, USA) 
according to manufacturer’s instructions. Reverse 
transcription was completed using gene-specific prim-
ers for PfPM VII, PfPM X and Pfs25 with SuperScript 
III first-strand synthesis system (Invitrogen, Carlsbad, 
CA, USA) according to manufacturer’s instructions. 
PCR on resulting cDNA was done using Platinum PCR 
SuperMix High Fidelity (Invitrogen, Carlsbad, CA, 
USA) with 250  nM of the same gene-specific prim-
ers for: Pfs25 (Fwd 5′-tgcgaaagttaccgtggatactg-3′; Rev 
5′-tgcgaaagttaccgtggatactg-3′), PfPM VII (Fwd 5′-gcgcc 
atgggtaaaaatgaagaattcacgaatccttattcc-3′, Rev 5′-gcgctc 
gagccttaaggttacatttcttttacttctaac-3′) and PfPM X (Fwd 
5′- gtgatgaagaaagttacgttatatttgacacagg-3′; Rev 5′-gctctt 
gctactccaaccatagaagg-3′). Thirty-five cycles were run 
with an annealing temperature of 55  °C and an exten-
sion temperature of 68 °C.
Production of recombinant PfPM VII and PfPM X 
in Escherichia coli
PfPM VII and PfPM X genes were amplified from 
genomic NF54 DNA to generate a gene that lacked the 
signal peptide. PCR products were gel purified on a 0.8 % 
agarose gel using the PureLink gel extraction kit (Invit-
rogen, Carlsbad, CA, USA), ligated into pCR4-TOPO 
(Invitrogen, Carlsbad, CA, USA), transformed into 
Top10 competent cells (Invitrogen, Carlsbad, CA, USA) 
and sequence-verified (Eton Bioscience, San Diego, CA, 
USA). PfPM VII and PfPM X genes were then cloned into 
expression vectors pET32 and pGEX 4T-1 (GE Health-
care, Piscataway, NJ, USA), respectively.
The recombinant PfPM VII-HIS-tagged (rPfPM VII-
HIS) and PfPM X-GST-tagged (rPfPM X-GST) fusion 
proteins were expressed in Rosetta (Merck/Novagen, 
Darmstadt, Germany) competent cells according to 
standard protocol [46]. Briefly, competent cells were 
transformed with 250–500 ng of purified plasmid DNA, 
streaked on LB agar plates embedded with 100  µg/ml 
ampicillin and allowed to grow overnight at 37 °C. Fresh 
colonies were inoculated and grown to OD600 0.5–1. Pro-
tein expression was then induced with 0.3  mM isopro-
pyl β-D-1-thiogalactopyranoside (IPTG) for 0.5–18  h at 
18 °C.
For rPfPM VII and rPfPM X protein verification, inclu-
sion bodies were purified using BugBuster extraction rea-
gent (Merck/Novagen, Darmstadt, Germany) and run on a 
4–20 % Tris–Glycine SDS-PAGE gel that was then stained 
with Coomassie blue. A stained SDS-PAGE gel slice con-
sistent with the predicted size of rPfPM VII-HIS and 
rPfPM X-GST fusion protein was excised and processed 
for mass spectrometry analysis (The Scripps Research 
Institute, La Jolla, CA, USA). The gel slices were destained 
and proteins were reduced with 10  mM DTT, alkylated 
with 55  mM iodoacetamide and digested in-gel with 
trypsin as previously described [47, 48]. Samples were ana-
lysed by mass spectrometry, and identified peptides were 
searched by BLAST against the P. falciparum genome.
Production of monoclonal antibodies against PfPM VII 
and PfPM X
PfPM VII peptide sequences EEFTNPYSIRKKDI, IQPD-
EQSEEDNVDG, and KIGFVRSKRNVTLR were derived 
from predicted immunogenic regions of the PfPM VII 
protein sequence using resources freely available from 
the Immune Epitope Database (iedb.org). PfPM X pep-
tide sequences KKLQKHHESLKLGDVKYYV, VRNQT-
FGLVESES, and LKESYWEVKLD were derived from 
predicted immunogenic regions of the PfPM X protein 
sequence (Fig.  1). These synthetic peptides were cre-
ated with an N-terminal cysteine to facilitate coupling 
to bovine serum albumin (BSA) as the antigenic carrier 
protein. Peptide composition was confirmed by mass 
spectrometry, and HPLC-purified peptides were used 
to immunize mice. The resulting hybridoma superna-
tants were screened against three sets of BSA-conjugated 
synthetic peptides, the same used to immunize mice, by 
enzyme linked immunosorbent assay (ELISA; A&G Phar-
maceuticals, Columbia, MD, USA). Secondary screening 
of ELISA-positive supernatant was performed by west-
ern immunoblot assay against full-length rPfPM VII-HIS 
or rPfPM X-GST. Hybridoma lines generating mAb that 
screened positive in both ELISA and Western immu-
noblot assays were grown in Dulbecco’s modified eagle 
medium (DMEM, CellGro, Herndon, VA, USA) sup-
plemented with 10  % fetal calf serum. Antibodies were 
either concentrated from hybridoma supernatant or puri-
fied mAb in PBS (A&G Pharmaceuticals, Columbia, MD, 
USA).
After screening against rPfPM VII, two lines, 1B4 and 
2B1, generated antibodies directed against each cata-
lytic domain of PfPM VII. After screening against rPfPM 
X, one line, 6A9, generated antibody directed against 
the pro-enzyme domain, and one line, 3G6, generated 
antibody directed against the catalytic domain (Fig.  2). 
mAb 6A9 was directed against a peptide region unique 
to PfPM X while 3G6 is directed against a peptide region 
that is moderately conserved with PfPM IX (Fig. 2).
Immunofluorescence assay
Fixed, permeabilized P. falciparum gametocytes, gam-
etes, zygotes and ookinetes were analysed by IFA. Para-
sites were fixed on glass slides with 100  % acetone at 
−20  °C for at least 20  min and then rehydrated by two 
changes of PBS for 5 min each at room temperature. For 
membrane permeabilization and blocking of nonspecific 
binding, fixed cells were incubated in PBS supplemented 
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with 3 % bovine serum albumin and 0.1 % Triton X-100 
for 1 h at room temperature. The preparations were then 
incubated with mAb (1:1000 dilution) for 1  h at room 
temperature followed by either FITC-conjugated anti-
mouse IgG or Alexa Fluor 488 rabbit anti-mouse IgG 
(1:200 dilution) (Molecular Probes, Invitrogen, USA). 
Nuclei were visualized with 300  nM DAPI (4, 6-diami-
dino-2-phenylindole) (Pierce Biotechnology, Rockford, 
IL, USA). Slides were washed an additional six times 
in Tris-buffered saline (TBS) for a total of 30  min then 
mounted with coverslips using Dako mounting medium 
(Dako, Carpinteria, USA). Preparations were examined 
by deconvolution microscopy using an Olympus BX51 
fluorescence microscope and Olympus DP71 camera 
(Olympus, Center Valley, CA, USA).
Immunoelectron microscopy localization of PfPM VII 
and PfPM X
Cells were fixed with 2.5 % glutaraldehyde in 0.1 M caco-
dylate buffer for 2  h at room temperature, postfixed in 
1 % OsO4 in 0.1 M cacodylate buffer (1 h) at room tem-
perature, and embedded in LX-112 (Ladd Research, 
Williston, VT), as described previously [49]. Cryosec-
tions were made, applied to grids, blocked in 1 % BSA in 
PBS for 1 h, incubated in 1:500 dilution of mAb against 
PfPM VII, PfPM X or IgG isotype control, washed and 
incubated with anti-mouse IgG conjugated to 5 nm col-
loidal gold particles as described previously [50]. Stained 
sections were examined using a Philips CM-10 electron 
microscope.
Western immunoblot analysis
Plasmodium falciparum parasites were purified, pel-
leted and resuspended in 250 µl of lysis buffer (4 M urea, 
0.4 % Triton X-100, 50 mM Tris, 5 mM EDTA, 10 mM 
MgSO4, pH 8.0) supplemented with Complete protease 
inhibitor cocktail (Roche Applied Sciences, Indianapo-
lis, IN, USA). Parasites were processed by three cycles of 
freeze–thaw lysis followed by sonication on ice for 5 min 
in 30  s bursts using a Misonix Sonicator 3000 with an 
output setting of 7 (Misonix, Farmingdale, NY, USA). 
Protein concentrations were determined by BCA assay 
(Bio-Rad, Hercules, CA, USA). 100  µg of each sample 
was mixed with Laemmli SDS-loading buffer (160  mM 
Tris, 10  % SDS, 20  % glycerol, 5  % 2-mercaptoethanol, 
0.01 % bromophenol blue, pH 8.0) and boiled for 10 min. 
Proteins were separated on Novex 10–20 % SDS-PAGE 
mini-gels (Invitrogen, Carlsbad, CA 92008 USA) and 
transferred to nitrocellulose membranes. Membranes 
were blocked in TBS/5 % non-fat milk/0.05 % Tween-20, 
Fig. 1 Plasmepsin VII and Plasmepsin X mRNA was detected in 
Plasmodium falciparum sexual stage parasites. a Total RNA isolated 
from in vitro-cultivated asexual stages (A), gametocytes (G), zygotes 
(Z), ookinetes (O), and uninfected human erythrocytes (uB). Samples 
were reverse transcribed and amplified using primers specific for 
PfPM VII (+RT). Samples that were not reverse transcribed (−RT) and 
amplified with PfPM VII-specific primers did not generate PCR prod-
uct. b Total RNA isolated ex vivo from ookinete-containing mosquito 
midguts (O) or uninfected human blood (uB), in vitro-cultivated 
gametocytes (G) and mixed zygotes and ookinetes (Z/O), as well 
as DNA from P. falciparum (NF) was isolated. Samples were reverse 
transcribed and amplified using primers specific for PfPM X and pfs25 
(+RT). Samples that were not reverse transcribed (−RT) and ampli-
fied with PfPM X-specific primers did not generate PCR product
Fig. 2 Peptide monoclonal antibodies directed against Plasmodium 
falciparum Plasmepsin VII and Plasmepsin X. a Schematic representa-
tion of Plasmepsin showing the predicted signal peptide (blank), 
pro-enzyme domains (pro), and catalytic domain (cat). Peptide mono-
clonal antibodies designed against three regions of PfPM VII and PfPM 
X are designated prodomain (PD, black), catalytic domain 1 (CD1, red) 
and catalytic domain 2 (CD2, purple). b Protein sequence of PfPM VII 
and c. PfPM X showing the predicted signal peptide (blue) and the 
predicted pro-enzyme domain (italics); the two active aspartic acid 
residues (red) are found within conserved regions (bold). Monoclonal 
antibody targets to prodomain (black), CD1 (red), and CD 2 (purple). d 
Alignment of 3G6 peptide target between all P. falciparum plas-
mepsins shows moderate conservation between PfPM X and PfPM IX 
at this site
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pH 8.0 for 1 h. Blots were probed with primary antibody 
diluted 1:2000 in blocking buffer for 1  h. Following six 
10-min washes in blocking buffer, blots were probed 
with peroxidase-conjugated anti-mouse secondary anti-
body diluted 1:20,000 in blocking buffer. Blots were 
washed six times in blocking buffer, twice in TBS and 
then developed with chemiluminescent substrate (KPL, 
Gaithersburg, MD, USA).
Membrane feeding assays
Standard membrane feeding assays (SMFA) were 
performed to determine the ability of antibodies 
against Pf PMVII and PfPMX to affect infectivity of 
P. falciparum for mosquitoes. One day prior to the 
assay, female An. stephensi or An. gambiae mosqui-
toes aged 3–7  days post-emergence were segregated 
into cartons of 40–60 mosquitoes, and starved over-
night. Mature P. falciparum gametocytes were exam-
ined for their ability to exflagellate and only those 
cultures with at least 10 exflagellating centres per 
40X field were used for SMFA. Cultures with mature 
gametocytes were mixed with fresh human serum 
and red blood cells, plus antibodies, then fed to An. 
stephensi or An. gambiae using water-jacketed glass 
membrane feeders as previously described [14]. Iso-
type immunoglobulin G2b (IgG2b) was used as a 
negative control. Twenty minutes after the start of 
the feed, membrane feeders were disengaged and 
non-engorged mosquitoes were removed from car-
tons. P. falciparum-infected mosquitoes were kept 
in a secured incubator separate from non-infected 
mosquitoes. Infected mosquitoes were fed with 8  % 
fructose/0.05 % p-aminobenzoic acid in sterile water 
ad libitum and maintained at 26–28 °C and 80 % rela-
tive humidity [51, 52].
On day 8–10 post blood meal, mosquito midguts 
were dissected, stained with mercurochrome and 
examined with a light microscope for the presence of 
oocysts [52]. All manipulations were done in accord-
ance with UCSD IACUC-approved protocol for non-
vertebrate research animals. Differences in infection 
rate and geometric means between test mAb and 
negative control groups were assessed using the non-
parametric Mann–Whitney U test. Samples were 
considered to be statistically significant at a p value 
≤0.01.
Results
PfPM VII and PfPM X mRNA was transcribed in P. falciparum 
sexual stages
RT-PCR of RNA isolated from P. falciparum sexual stage 
parasites generated in vitro and dissected from mosqui-
toes ex  vivo demonstrated that PfPM VII and PfPM X 
mRNA was detected in gametocytes and mixed zygotes/
ookinetes (Fig.  1). Conventional PCR of RNA samples 
not treated with reverse transcriptase did not produce 
PCR product and demonstrated that RNA samples were 
DNA free (Fig. 1).
PfPM VII and PfPM X protein expression in sexual stage 
parasites
IFA of P. falciparum sexual stage parasites using mAbs 
directed against PfPM VII and PfPM X demonstrated 
diffuse, cytoplasmic localization in P. falciparum zygotes 
and ookinetes but not gametocytes (Fig.  3). Neither 
PfPM VII nor PfPM X were found to be localized within 
specific sub-cellular compartments, such as micronemes 
or endoplasmic reticulum, or the ookinete cell surface as 
determined by immunoelectron microscopy.
Western immunoblot confirmed IFA results dem-
onstrating PfPM VII and PfPM X protein expression in 
sexual stage parasites. Antibody 2B1 recognized a sin-
gle ~ 46 kDa band in ookinetes but no other sexual stage 
parasite; this protein is close to the predicted 52  kDa 
size of the full length protein and the 42 kDa size of the 
PfPM VII catalytic domain (Fig. 3). Antibodies 6A9 and 
3G6 recognized multiple bands in mixed gamete/zygote 
samples and ookinete samples, but not gametocyte sam-
ples. Antibody 6A9 recognized two bands: a 56–60 kDa 
protein, consistent with the predicted 61 kDa size of full 
length PfPM X, and a faint 17–25 kDa protein, consistent 
with the predicted 23 kDa size of the PfPM X pro-enzyme 
domain. Antibody 3G6 also recognized a 56–60 kDa pro-
tein in addition to a faint 32–40 kDa protein, consistent 
with the predicted 36  kDa size of the catalytic domain. 
Of note, 6A9 and 3G6 recognized two bands in parasite 
lysate, one at 42–55  kDa and the second at 27–30  kDa; 
these bands were also recognized by IgG isotype control 
antibody, indicating that these protein bands are non-
specific (Fig. 3).
Antibodies directed against PfPM VII or PfPM X moderately 
decreased Plasmodium falciparum transmission 
to Anopheles in SMFAs
To determine whether antibodies against either PfPM 
VII or PfPM X could affect P. falciparum transmission to 
mosquitoes, female An. stephensi and An. gambiae were 
fed infectious gametocytes mixed with 1B4, 2B1, 6A9, 
3G6 or isotype IgG negative control antibodies, respec-
tively, in SMFAs (Table  1, 2). Mosquito midguts were 
dissected 8–10 days post-blood meal to determine preva-
lence and intensity of infection.
The presence of antibodies directed against either 
PfPM VII or PfPM X in an infectious blood meal sig-
nificantly decreased P. falciparum transmission to mos-
quitoes at high antibody concentrations (Tables  1, 2). 
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Mosquitoes fed an infectious bloodmeal with 200  µg/
ml of 1B4 or 400  µg/ml of 2B1 had a 35–71.4 or 9.7–
23.5  % reduction in prevalence compared to groups fed 
with IgG isotype control antibody (Table  1). Addition-
ally, oocyst intensity of infected mosquitoes fed with1B4 
or 2B1 was reduced by 81–97 or 56–65  % compared to 
IgG isotype control (p value  <  0.01) (Table  1). Mosqui-
toes fed an infectious blood meal with 100 or 200 µg/ml 
of 3G6 had a 18 or 33  % reduction in prevalence com-
pared to IgG isotype control (Table 2). Additionally, the 
oocyst intensity of infected mosquitoes fed with 100 μg/
ml of 3G6 was reduced by 35 % compared to IgG isotype 
control, the oocyst intensity of infected mosquitoes fed 
with 200 μg/ml of 3G6 was reduced by 42 % compared to 
IgG isotype controls (p value < 0.01) (Table 2). The pres-
ence of 200 µg/ml of 6A9 in an infectious bloodmeal only 
reduced P. falciparum transmission to mosquitoes by 
13 %, and oocyst intensity was comparable to IgG isotype 
controls (Table 2).
Further attempts were made to elucidate the precise 
role of PfPM VII and PfPM X during P. falciparum sexual 
development and transmission to mosquitoes. Unfortu-
nately, we were unable to produce active, recombinant 
protease in either an E. coli-based expression system or 
a cell-free wheat germ expression system. The generation 
of PfPM VII and PfPM X knockout parasites were unsuc-
cessful (Additional files 1, 2).
Discussion
The data reported here indicate that that PfPM VII and 
PfPM X are expressed in ookinetes and contribute to P. 
falciparum transmission to Anopheles mosquitoes. This 
is the first observation that these plasmepsins play an 
important role in Plasmodium infection of mosquitoes. 
Transcriptomic data from all the life cycle stages of P. 
falciparum demonstrate mRNA expression of PfPM VII 
and PfPM X in sexual stage forms. These previously pub-
lished microarray data were confirmed by RT-PCR on 
in  vitro-cultivated gametocytes, gametes, zygotes and 
ookinetes and ex  vivo-harvested zygotes and ookinetes. 
Anti-peptide monoclonal antibodies directed against 
PfPM VII or PfPM X demonstated that these proteins are 
expressed in sexual stage parasite forms. Interestingly, 
PfPM VII and PfPM X mRNAs are expressed in P. falci-
parum gametocytes, but protein was not detected until 
zygote and gamete development, respectively. This incon-
sistency between mRNA and protein expression was not 
explored in this work, but this pattern suggests that PfPM 
Fig. 3 PfPM VII and PfPM X expression in Plasmodium falciparum sexual stage parasites demonstrated by IFA and western immunoblot. IFA of 
in vitro-cultivated parasites was performted using primary antibodies 1B4, 2B1, 6A9, 3G6 or isotype IgG2b and subsequently labelled with Alexa 
Fluor 488-labelled anti-mouse antibodies (green); nuclei are visualized with DAPI (blue). a IFA of in vitro-cultivated P. falciparum demonstrated 
PfPM VII expression in zygotes (Z) and ookinetes (O). b IFA of in vitro-cultivated P. falciparum demonstrated PfPM X expression in zygotes (Z) and 
ookinetes (O) but not gametocytes (G). c Western immunoblot analysis of total protein isolated from P. falciparum sexual stage parasites. Antibodies 
directed against PfPM VII recognized a ~46 kDa protein expressed in ookinetes (O) but not gametocytes (G). This protein is between the predicted 
sizes of full length PfPM VII at 52 kDa and the catalytic domain at 43 kDa. d Western immunoblot analysis of total protein isolated from P. falciparum 
sexual stage parasites. Both 6A9 and 3G6 recognized protein expressed in mixed gametes and zygotes (m/Z) and ookinetes (O) but not gameto-
cytes (G). Bands are consistent with the predicted sizes of full length PfPM X at 61 kDa (←F), the PfPM X catalytic domain at 36 kDa (←C), and the 
PfPM X proenzyme domain at 23 kDa (←P). IgG isotype control did not recognize the 61 kDa or 23 kDa bands on western immunoblot but contin-
ued to recognize the bands at 42–55 kDa and 27–30 kDa
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VII and PfPM X protein expression may be regulated by 
translational repression, a mechanism used to regulate 
other Plasmodium sexual stage proteins [53–58]. Simi-
lar observations have been seen with Pfs25 and chitinase, 
whose mRNAs but not proteins have been detected in 
gametocytes [50, 59].
Another mechanism to regulate protease activity is 
zymogen processing. Plasmepsins are known to har-
bour a proenzyme domain that functions to maintain the 
enzyme in a catalytically inactive state. Plasmepsins only 
become catalytically active when the proenzyme domain 
is cleaved and separated from the catalytic domain. Both 
PfPM VII and PfPM X contain predicted proenzyme 
domains. Western immunoblot of all three mAbs target-
ing PfPM VII only detected one protein in parasite lysate; 
this finding was unexpected as PfPM VII also contains a 
predicted proenzyme domain. Additionally, the protein 
recognized is smaller than the predicted size of the full-
length enzyme but large than the predicted size of the 
PfPM VII catalytic domain. Although we would expect 
to see two bands corresponding to the full-length protein 
and the proenzyme domain alone, it is possible that PfPM 
VII is not processed and activated in the ookinete. If 
PfPM VII is secreted or cell-surface associated, a hypoth-
esis not currently supported by IFA or immunoelectron 
data, it is possible that proenzyme domain is cleaved 
outside of the parasite. Given this result, it is likely that 
the full-length protein is processed at a site upstream of 
the mAb target region but that the proenzyme domain 
has not yet been cleaved in the ookinete, resulting in a 
smaller-than expected full-length protein. Western 
immunoblot analysis demonstrated that 6A9, which tar-
gets the PfPM X proenzyme domain, recognized proteins 
consistent with the sizes of the full-length enzyme and 
the cleaved pro-enzyme domain while 3G6, which tar-
gets the catalytic domain, recognized proteins consistent 
with the sizes of the full-length enzyme and the cleaved 
catalytic domain. This observation suggests that PfPM X 
is processed, and potentially catalytically active, during 
P. falciparum sexual stage development. Western immu-
noblot demonstrate that both PfPM VII and PfPM X are 
processed, and that PfPM X is likely catalytically active in 
the ookinete.
The majority of proteins that are both important for 
Plasmodium transmission to mosquitoes and good tar-
gets for transmission-blocking vaccines are either local-
ized to the parasite cell surface or secreted from the 
ookinete. Cell-surface proteins, such as P25/P28, medi-
ate parasite-host interactions and may be essential com-
ponents of signalling-pathways important for ookinete 
motility [15, 19, 21, 60]. Similarly, ookinete-secreted 
Table 1 Effect of mAbs against PfPM VII on Plasmodium falciparum infectivity to Anopheles stephensi mosquitoes
mAbs and IgG isotype control data from three independent SMFAs. Transmission-blocking activities measured as effects on intensity and prevalence. 
* Statistical significance determined by Mann–Whitney U test, control versus mAb, p value ≤0.01




Prevalence (no. infected/total 
engorged mosquitoes)
1 200 μg/ml IgG negative 2.28 0–10 31/39 (79.5 %)
200 μg/ml 1B4 0.07* 0–2 3/37 (8.1 %)
400 μg/ml IgG negative 22.18 7–58 24/24 (100 %)
400 ug/ml 2B1 7.7* 0–54 13/17 (76.5 %)
2 200 μg/ml IgG negative 24.23 0–121 34/40 (85.0 %)
200 μg/ml 1B4 3.47* 0–45 20/40 (50.0 %)
400 μg/ml IgG negative 9.15 0–88 29/38 (76.3 %)
400 μg/ml 2B1 3.17* 0–81 20/33 (66.6 %)
3 200 μg/ml IgG negative 12.67 0–55 35/40 (87.5 %)
200 μg/ml 1B4 2.41* 0–29 8/19 (42.1 %)
400 μg/ml IgG negative 14.74 0–68 31/32 (96.9 %)
400 μg/ml 2B1 6.5* 0–65 29/34 (85.3 %)
Table 2 Effect of mAbs against PfPM X on Plasmodium fal-
ciparum infectivity to Anopheles gambiae mosquitoes
mAbs and IgG isotype control data from triplicate SMFAs under the same 
conditions, data combined. Transmission-blocking activities measured as effects 
on intensity and prevalence
* Statistical significance determined by Mann–Whitney U test, control versus 
mAb, p value ≤0.01








200 μg/ml IgG 
negative
2.6 0–55 62/80 (77.5 %)
100 μg/ml 3G6 1.7 0–108 48/80 (60.0 %)
200 μg/ml 3G6 1.5* 0–148 34/76 (44.7 %)
200 μg/ml 6A9 2.4 0–59 33/51 (64.7 %)
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proteins and enzymes, such as chitinase, CTRP and 
WARP, modify the mosquito midgut environment to 
allow Plasmodium invasion and infection of the mos-
quito midgut [13, 14, 17, 18]. Neither PfPM VII nor PfPM 
X localized to the parasite cell surface or micronemes. 
IFA and immunoelectron microscopy demonstrated dif-
fuse cytoplasmic localization of mAbs directed against 
PfPM VII and PfPM X.
Previous studies showed that pepstatin A, an aspartic 
protease-specific inhibitor, ALLN and ALLM, two plas-
mepsin convertase inhibitors, interrupted Plasmodium 
transmission to mosquitoes [38]. The presence of anti-
bodies directed against PfPM VII or PfPM X significantly 
reduced P. falciparum infection of Anopheles. However, 
relatively high concentrations of 1B4, 2B1 and 3G6 were 
required to achieve an effect. It is possible that the anti-
bodies had low affinity, resulting in the low level of inter-
ruption of the transmission. It is also possible that these 
Plasmepsins were important, but not essential, for P. fal-
ciparum transmission to Anopheles mosquitoes, consist-
ent with previous reports with a P. berghei Plasmepsin VII 
knockout mutant [61]. Equally, if not more likely is the 
possibility that loss of PfPM VII or PfPM X function in 
the presence of mAb was compensated for by the action 
of related proteases, such as Plasmepsin IX, which are 
similarly upregulated in sexual stage parasite forms [29]. 
The equivocal result seen in SMFAs using 6A9, directed 
against the PfPM X proenzyme domain, is expected if the 
proenzyme domain of PfPM X is cleaved and no longer 
associated with the activated catalytic domain in ookine-
tes. These data indicate that there is still much to learn 
about the role of plasmepsins in Plasmodium transmis-
sion to mosquitoes. Further work is needed to explore 
these interesting possibilities.
Conclusions
Knowledge of the Plasmodium sexual cycle and the 
molecular mechanisms underlying ookinete invasion 
of the mosquito midgut is essential for understanding 
parasite developmental programmes and parasite-mos-
quito interactions. In this study, we have investigated 
the expression and functional significance of PfPM VII 
and PfPM X in malaria transmission to mosquitoes. We 
demonstrated that these proteins are expressed in P. fal-
ciparum ookinetes and that antibodies directed against 
these proteins reduced parasite transmission to Anoph-
eles mosquitoes when used at high concentration in mos-
quito infection experiments. This observation suggests 
that PfPM VII and PfPM X facilitate Plasmodium infec-
tion of mosquitoes. This data complements discoveries 
demonstrating that P. gallinaceum plasmepsin IV was 
important for parasite infection of the mosquito vector 
[38] and P. berghei plasmepsin VII was dispensable in its 
life cycle [61]. Together, these results suggest that plas-
mepsins expressed in the Plasmodium ookinete function 
in ways distinct from plasmepsins expressed in asexual 
parasites. These findings raise a number of interest-
ing questions. What other plasmepsins are expressed in 
sexual stage parasites? If these plasmepsins are involved 
in midgut invasion or sexual stage parasite development, 
what pathways are involved? Further investigation of the 
role(s) of plasmepsins during sexual development and 
invasion of mosquitoes will likely lead to novel insights 
into Plasmodium biology and provide new targets for 
transmission-blocking vaccines.
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